The Entire Annual Report

• All pages, 2 pages spread [PDF 8.0MB / 50Pages]
• All pages, single page [PDF 8.3MB / 98Pages]

Main Contents

Show more

Introduction

• Looking Ahead to 2030
• Themes of the Year

Initiatives

• Message from the CEO
• History of Value Creation
• Value Creation Model
• Creation of Shared Value
• Overview of TOP I 2030
• Sources of Shared Value Creation
• Material Issues
• Executive Officers

Progress

• Progress in R&D
• Focus: Accelerating Expansion of Innovative New Drugs―Progress of Multi-Modality Strategy
• Strategy Implementation (Drug Discovery, Development, Pharmaceutical Technology, Value Delivery, Foundation for Growth)
• Dialogue with Stakeholders and External Evaluation
• Message from the CFO

Governance

• Message from the Chair of the Appointment Committee
• Message from the Chair of the Compensation Committee
• Message from the Chair of the Special Committee
• Directors / Audit & Supervisory Board Members
• Corporate Governance
• Risk Management

Performance Data

• Financial and Pre-Financial Highlights (IFRS)
• Review by Product
• Development Pipeline
• Consolidated Financial Indicators
• Management’s Discussion and Analysis
• Shareholder Information
• Corporate Profile